Genetic and epigenetic markers in colorectal cancer screening: recent advances
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic and epigenetic markers in colorectal cancer screening: recent advances
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 17, Issue 7, Pages 665-685
Publisher
Informa UK Limited
Online
2017-06-01
DOI
10.1080/14737159.2017.1337511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Utility of comprehensive genomic sequencing for detecting HER2-positive colorectal cancer
- (2017) Yoshifumi Shimada et al. HUMAN PATHOLOGY
- Bioactive Nutrients and Nutrigenomics in Age-Related Diseases
- (2017) Tania Rescigno et al. MOLECULES
- A novel epigenetic immunoassay approach to profiling circulating nucleosomes for CRC detection
- (2016) M. Herzog et al. ANNALS OF ONCOLOGY
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Epigenetic biomarkers in colorectal cancer: premises and prospects
- (2016) Mozhdeh Zamani et al. BIOMARKERS
- A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
- (2016) Farshad Farshidfar et al. BRITISH JOURNAL OF CANCER
- Abstract 4920: Evaluation of a diagnostic blood test for colorectal cancer screening and as a triage tool to stratify patients for colonoscopy
- (2016) Leah J. Cosgrove et al. CANCER RESEARCH
- Abstract 968: Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer
- (2016) Yuji Toiyama et al. CANCER RESEARCH
- Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer
- (2016) Petra Vychytilova-Faltejskova et al. CARCINOGENESIS
- Telomere Length as a Prognostic Factor for Overall Survival in Colorectal Cancer Patients
- (2016) Houjun Jia et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer
- (2016) Y. F. Song et al. Clinical & Translational Oncology
- MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival
- (2016) K. Mima et al. CLINICAL CANCER RESEARCH
- Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target
- (2016) E. Yakirevich et al. CLINICAL CANCER RESEARCH
- Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker
- (2016) Oriol Caritg et al. Clinical Colorectal Cancer
- PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies
- (2016) L. Paleari et al. CLINICAL ONCOLOGY
- Review Article
- (2016) Shuji Ogino et al. EPIDEMIOLOGY
- NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics
- (2016) Hin-Fung Tsang et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia
- (2016) Sunny H Wong et al. GUT
- Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer
- (2016) Melanie Maierthaler et al. INTERNATIONAL JOURNAL OF CANCER
- Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer
- (2016) Chen Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases
- (2016) Umberto Malapelle et al. JOURNAL OF CLINICAL PATHOLOGY
- Biomarkers in Colorectal Cancer Screening
- (2016) Minhhuyen T. Nguyen et al. Journal of the National Comprehensive Cancer Network
- Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
- (2016) Andrea Sartore-Bianchi et al. LANCET ONCOLOGY
- Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors
- (2016) Luke B. Hesson et al. MOLECULAR CANCER RESEARCH
- EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer
- (2016) Sajid A. Khan et al. PATHOLOGY & ONCOLOGY RESEARCH
- Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis
- (2016) Roi Villar-Vázquez et al. PROTEOMICS
- New trends in molecular and cellular biomarker discovery for colorectal cancer
- (2016) Parisa Aghagolzadeh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis
- (2016) Nina Yu et al. OncoTargets and Therapy
- DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer
- (2016) Yutaka Hashimoto et al. Epigenomics
- Validation of targeted next-generation sequencing forRASmutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR
- (2016) Jie Gao et al. BMJ Open
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
- (2016) Marios Giannakis et al. Cell Reports
- Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer
- (2016) Tamara Fernández-Marcelo et al. PLoS One
- P-192 * DNA methylation profile of APC and DKK2 genes as biomarkers in colorectal cancer patients
- (2015) T. da Silva et al. ANNALS OF ONCOLOGY
- DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis
- (2015) Ming-Hong Tsai et al. ANNALS OF SURGICAL ONCOLOGY
- MiR-320e is a novel prognostic biomarker in colorectal cancer
- (2015) L Perez-Carbonell et al. BRITISH JOURNAL OF CANCER
- MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a
- (2015) Jiaojiao Zhou et al. CANCER LETTERS
- Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
- (2015) Yoshinaga Okugawa et al. GASTROENTEROLOGY
- Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer
- (2015) John M. Carethers et al. GASTROENTEROLOGY
- Molecular markers for colorectal cancer screening
- (2015) Brandon T Dickinson et al. GUT
- Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
- (2015) Jun Yu et al. GUT
- Association ofFusobacterium nucleatumwith clinical and molecular features in colorectal serrated pathway
- (2015) Miki Ito et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer
- (2015) Cristina Caramés et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer
- (2015) Jennifer Ng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD
- (2015) Jie Chai et al. IUBMB LIFE
- Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm
- (2015) Peng Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer
- (2015) Gholam Basati et al. TUMOR BIOLOGY
- Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas
- (2015) Xie Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer
- (2015) Mallikarjuna Uppara et al. World Journal of Surgical Oncology
- Molecular Features and Methylation Status in Early Onset (≤40 Years) Colorectal Cancer: A Population Based, Case-Control Study
- (2015) Giulia Magnani et al. Gastroenterology Research and Practice
- New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
- (2015) Giuseppe Bronte et al. Oncotarget
- MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer
- (2015) Femke Simmer et al. Oncotarget
- A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer
- (2015) Nada A. Al-Tassan et al. Scientific Reports
- Colorectal Cancer Biomarkers: Where Are We Now?
- (2015) Maria Gonzalez-Pons et al. Biomed Research International
- Epigenetic inactivation of the extracellular matrix metallopeptidase ADAMTS19 gene and the metastatic spread in colorectal cancer
- (2015) Sergio Alonso et al. Clinical Epigenetics
- MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing
- (2015) M Neerincx et al. Oncogenesis
- Molecular phenotypes of colorectal cancer and potential clinical applications
- (2015) Jonathan M. Kocarnik et al. Gastroenterology Report
- A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer
- (2015) Susanne K. Pedersen et al. PLoS One
- ExtendedRASmutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
- (2014) M. J. Sorich et al. ANNALS OF ONCOLOGY
- Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
- (2014) Y. Y. Juo et al. ANNALS OF ONCOLOGY
- Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer
- (2014) Hisayoshi Igarashi et al. ANNALS OF SURGICAL ONCOLOGY
- Systematic review/Meta-analysis Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients
- (2014) Lulu Huang et al. Archives of Medical Science
- Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells
- (2014) Nami Yamada et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro
- (2014) Zhang Hong et al. BMB Reports
- MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma
- (2014) Zhao Sun et al. BMC CANCER
- Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway
- (2014) B Zhang et al. BRITISH JOURNAL OF CANCER
- The Human Gut Microbiome as a Screening Tool for Colorectal Cancer
- (2014) J. P. Zackular et al. Cancer Prevention Research
- CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer
- (2014) A. H. G. Cleven et al. CLINICAL CANCER RESEARCH
- Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma
- (2014) C. W. Wu et al. CLINICAL CANCER RESEARCH
- An update on microRNAs as colorectal cancer biomarkers: where are we and what’s next?
- (2014) Yoshinaga Okugawa et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis
- (2014) Lauren R. Zeitels et al. GENES & DEVELOPMENT
- Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis
- (2014) Peiwei Li et al. GUT
- Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
- (2014) Elzbieta Szmida et al. JOURNAL OF APPLIED GENETICS
- The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer
- (2014) Martin L. Read et al. MOLECULAR CARCINOGENESIS
- MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells
- (2014) Wei-Lun Hwang et al. NATURE CELL BIOLOGY
- Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection
- (2014) Jia Wang et al. PLoS One
- The Detection of the Methylated Wif-1 Gene Is More Accurate than a Fecal Occult Blood Test for Colorectal Cancer Screening
- (2014) Aurelien Amiot et al. PLoS One
- Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
- (2014) Mogens K. Boisen et al. PLoS One
- A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer
- (2014) Fiona Day et al. Targeted Oncology
- Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance
- (2014) Rania Abdelmaksoud-Dammak et al. TUMOR BIOLOGY
- Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer
- (2014) Zhong-chuan Lv et al. TUMOR BIOLOGY
- MicroRNAs in colorectal cancer: Role in metastasis and clinical perspectives
- (2014) Shan Muhammad WORLD JOURNAL OF GASTROENTEROLOGY
- Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer
- (2014) Hui-Peng Wang WORLD JOURNAL OF GASTROENTEROLOGY
- MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer
- (2014) Verena Stiegelbauer WORLD JOURNAL OF GASTROENTEROLOGY
- A Plasma MicroRNA Panel for Detection of Colorectal Adenomas
- (2013) Ziad Kanaan et al. ANNALS OF SURGERY
- Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer
- (2013) Yuji Toiyama et al. ANNALS OF SURGERY
- The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
- (2013) V Eklöf et al. BRITISH JOURNAL OF CANCER
- Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motilityin vitroand drives tumor formationin vivo
- (2013) Yuhki Yokoyama et al. CANCER SCIENCE
- Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway
- (2013) K. Nosho et al. CARCINOGENESIS
- Risk of Cancer in Cases of Suspected Lynch Syndrome Without Germline Mutation
- (2013) María Rodríguez–Soler et al. GASTROENTEROLOGY
- Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis
- (2013) Keun Hur et al. GUT
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Coexistent mutations ofKRASandPIK3CAaffect the efficacy of NVP-BEZ235, a dual PI3K/MTOR inhibitor, in regulating the PI3K/MTOR pathway in colorectal cancer
- (2013) Areumnuri Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
- (2013) Dora Colussi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis
- (2013) Jia-Xing Zhang et al. LANCET ONCOLOGY
- HDAC Up-Regulation in Early Colon Field Carcinogenesis Is Involved in Cell Tumorigenicity through Regulation of Chromatin Structure
- (2013) Yolanda Stypula-Cyrus et al. PLoS One
- PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
- (2013) Christophe Rosty et al. PLoS One
- Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing
- (2013) Sae-Won Han et al. PLoS One
- Epigenetics and Colorectal Cancer Pathogenesis
- (2013) Kankana Bardhan et al. Cancers
- Plasma MiR-21
- (2012) Ziad Kanaan et al. ANNALS OF SURGERY
- Beyond KRAS mutation status: influence of KRAScopy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
- (2012) Leonie JM Mekenkamp et al. BMC CANCER
- miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4
- (2012) H.-Y. Chen et al. CANCER RESEARCH
- HIF-1α-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism
- (2012) Linna Fu et al. CARCINOGENESIS
- Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
- (2012) X. Liao et al. CLINICAL CANCER RESEARCH
- Circulating MicroRNAs as Biomarkers of Colorectal Cancer: Results From a Genome-Wide Profiling and Validation Study
- (2012) María Dolores Giráldez et al. Clinical Gastroenterology and Hepatology
- Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
- (2012) Claire Palles et al. NATURE GENETICS
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer
- (2012) Qifeng Wang et al. PLoS One
- MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
- (2012) Marek Svoboda et al. Radiation Oncology
- Recent approaches to identifying biomarkers for high-risk stage II colon cancer
- (2012) Takashi Akiyoshi et al. SURGERY TODAY
- Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130
- (2012) Yanlei Ma et al. Nature Communications
- A Tissue-Based Comparative Effectiveness Analysis of Biomarkers for Early Detection of Colorectal Tumors
- (2012) Deeqa Ahmed et al. Clinical and Translational Gastroenterology
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
- (2011) Jorja D Warren et al. BMC Medicine
- p53-Responsive miR-194 Inhibits Thrombospondin-1 and Promotes Angiogenesis in Colon Cancers
- (2011) P. Sundaram et al. CANCER RESEARCH
- miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer
- (2011) Akihiko Tsuchida et al. CANCER SCIENCE
- Promoter methylation of Wnt antagonistsDKK1andSFRP1is associated with opposing tumor subtypes in two large populations of colorectal cancer patients
- (2011) James B. Rawson et al. CARCINOGENESIS
- Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease
- (2011) Michael M. Vickers et al. CLINICAL & EXPERIMENTAL METASTASIS
- Stool Methylation-Specific Polymerase Chain Reaction Assay for the Detection of Colorectal Neoplasia in Korean Patients
- (2011) Yoo Hum Baek et al. DISEASES OF THE COLON & RECTUM
- MicroRNA profiling differentiates colorectal cancer according to KRAS status
- (2011) Neda Mosakhani et al. GENES CHROMOSOMES & CANCER
- Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps
- (2011) Chung Wah Wu et al. GUT
- Global histone modification of histone H3 in colorectal cancer and its precursor lesions
- (2011) Tadao Nakazawa et al. HUMAN PATHOLOGY
- A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
- (2011) Giuseppina Della Vittoria Scarpati et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer
- (2011) Murugan Kalimutho et al. JOURNAL OF GASTROENTEROLOGY
- Epigenetics and colorectal cancer
- (2011) Victoria Valinluck Lao et al. Nature Reviews Gastroenterology & Hepatology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
- (2011) Markus Vogt et al. VIRCHOWS ARCHIV
- Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
- (2010) M T de Bruijn et al. BRITISH JOURNAL OF CANCER
- DNA methylation markers in colorectal cancer
- (2010) Myoung Sook Kim et al. CANCER AND METASTASIS REVIEWS
- MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening
- (2010) Y. Koga et al. Cancer Prevention Research
- All about KRAS for clinical oncology practice: Gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer
- (2010) Helena Linardou et al. CANCER TREATMENT REVIEWS
- Novel Methylation Panel for the Early Detection of Colorectal Tumors in Stool DNA
- (2010) Daniel Azuara et al. Clinical Colorectal Cancer
- Hereditary and Familial Colon Cancer
- (2010) Kory W. Jasperson et al. GASTROENTEROLOGY
- The Chromosomal Instability Pathway in Colon Cancer
- (2010) Maria S. Pino et al. GASTROENTEROLOGY
- Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
- (2010) S. Ogino et al. GUT
- miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells
- (2010) Charisa L. Cottonham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
- (2010) Xing-xiang Pu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan
- (2010) V Boni et al. PHARMACOGENOMICS JOURNAL
- PI3-kinase/Wnt association mediates COX-2/PGE2 pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac
- (2010) Jasmeet Kaur et al. TUMOR BIOLOGY
- Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer
- (2009) S. C. Glockner et al. CANCER RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer
- (2009) D. M.E.I. Hellebrekers et al. CLINICAL CANCER RESEARCH
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
- (2009) E K O Ng et al. GUT
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
- (2009) Zhaohui Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer
- (2009) Shahab Uddin et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Significance and Molecular Associations of 18q Loss of Heterozygosity: A Cohort Study of Microsatellite Stable Colorectal Cancers
- (2009) Shuji Ogino et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
- (2009) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Fecal DNA Methylation to Detect Gastrointestinal Neoplasia
- (2009) Takeshi Nagasaka et al. JNCI-Journal of the National Cancer Institute
- N-Myc Downstream-Regulated Gene 4 ( NDRG4 ): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer
- (2009) Veerle Melotte et al. JNCI-Journal of the National Cancer Institute
- Promoter DNA Methylation of Oncostatin M receptor-β as a Novel Diagnostic and Therapeutic Marker in Colon Cancer
- (2009) Myoung Sook Kim et al. PLoS One
- Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer
- (2008) R. Nagel et al. CANCER RESEARCH
- Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma
- (2008) Hassan Ashktorab et al. DIGESTIVE DISEASES AND SCIENCES
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
- (2008) Aaron J. Schetter et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
- (2008) Heather R. Christofk et al. NATURE
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
- Clinical Oncology: Onward and Upward
- (2007) George P. Canellos JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started